Ceresoli Giovanni Luca, Cattaneo Giovanni Mauro, Castellone Pietro, Rizzos Giovanna, Landoni Claudio, Gregorc Vanesa, Calandrino Riccardo, Villa Eugenio, Messa Cristina, Santoro Armando, Fazio Ferruccio
Department of Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Milan, Italy.
Tumori. 2007 Jan-Feb;93(1):88-96. doi: 10.1177/030089160709300116.
Mediastinal elective node irradiation (ENI) in patients with non-small cell lung cancer candidate to radical radiotherapy is controversial. In this study, the impact of co-registered [18F]fluorodeoxyglucose-positron emission tomography (PET) and standard computed tomography (CT) on definition of target volumes and toxicity parameters was evaluated, by comparison with standard CT-based simulation with and without ENI.
CT-based gross tumor volume (GTVCT) was first contoured by a single observer without knowledge of PET results. Subsequently, the integrated GTV based on PET/CT coregistered images (GTVPET/CT) was defined. Each patient was planned according to three different treatment techniques: 1) radiotherapy with ENI using the CT data set alone (ENI plan); 2) radiotherapy without ENI using the CT data set alone (no ENI plan); 3) radiotherapy without ENI using PET/CT fusion data set (PET plan). Rival plans were compared for each patient with respect to dose to the normal tissues (spinal cord, healthy lungs, heart and esophagus).
The addition of PET-modified TNM staging in 10/21 enrolled patients (48%); 3/21 were shifted to palliative treatment due to detection of metastatic disease or large tumor not amenable to high-dose radiotherapy. In 7/18 (39%) patients treated with radical radiotherapy, a significant (> or =25%) change in volume between GTVCT and GTVPET/CT was observed. For all the organs at risk, ENI plans had dose values significantly greater than no-ENI and PET plans. Comparing no ENI and PET plans, no statistically significant difference was observed, except for maximum point dose to the spinal cord Dmax, which was significantly lower in PET plans. Notably, even in patients in whom PET/CT planning resulted in an increased GTV, toxicity parameters were fairly acceptable, and always more favorable than with ENI plans.
Our study suggests that [18F]-fluorodeoxyglucose-PET should be integrated in no-ENI techniques, as it improves target volume delineation without a major increase in predicted toxicity.
对于适合根治性放疗的非小细胞肺癌患者,纵隔选择性淋巴结照射(ENI)存在争议。在本研究中,通过与基于标准CT且有或无ENI的模拟进行比较,评估了联合注册的[18F]氟脱氧葡萄糖正电子发射断层扫描(PET)和标准计算机断层扫描(CT)对靶区体积定义和毒性参数的影响。
首先由一名不了解PET结果的观察者勾勒基于CT的大体肿瘤体积(GTVCT)。随后,定义基于PET/CT配准图像的综合GTV(GTVPET/CT)。每位患者根据三种不同的治疗技术进行计划:1)仅使用CT数据集进行ENI放疗(ENI计划);2)仅使用CT数据集不进行ENI放疗(无ENI计划);3)使用PET/CT融合数据集不进行ENI放疗(PET计划)。比较每位患者的竞争计划在正常组织(脊髓、健康肺、心脏和食管)的剂量。
10/21例入组患者(48%)增加了PET修正的TNM分期;3/21例因检测到转移性疾病或肿瘤较大不适合高剂量放疗而转为姑息治疗。在18例接受根治性放疗的患者中,7例(39%)观察到GTVCT和GTVPET/CT之间的体积有显著(≥25%)变化。对于所有危及器官,ENI计划的剂量值显著高于无ENI和PET计划。比较无ENI和PET计划,除脊髓最大点剂量Dmax外,未观察到统计学显著差异,PET计划中的Dmax显著更低。值得注意的是,即使在PET/CT计划导致GTV增加的患者中,毒性参数也相当可接受,且总是比ENI计划更有利。
我们的研究表明,[18F]氟脱氧葡萄糖-PET应纳入无ENI技术,因为它可改善靶区体积勾画,而不会大幅增加预测毒性。